4.6 Review

In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases

期刊

CURRENT MEDICINAL CHEMISTRY
卷 26, 期 23, 页码 4355-4379

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867325666180309114824

关键词

Neglected tropical diseases; drug repositioning; chemogenomics; similarity search; machine learning; pharmacophores; protein alignment; docking

资金

  1. Brazilian funding agency, CNPq
  2. Brazilian funding agency, CAPES
  3. Brazilian funding agency, FAPEG
  4. L'Oreal-UNESCO-ABC Para Mulheres na Ciencia
  5. L'Oreal-UNESCO International Rising Talents
  6. MCTI/CNPq [444001/2014-0]

向作者/读者索取更多资源

Only similar to 1% of all drug candidates against Neglected Tropical Diseases (NTDs) have reached clinical trials in the last decades, underscoring the need for new, safe and effective treatments. In such context, drug repositioning, which allows finding novel indications for approved drugs whose pharmacokinetic and safety profiles are already known, is emerging as a promising strategy for tackling NTDs. Chemogenomics is a direct descendent of the typical drug discovery process that involves the systematic screening of chemical compounds against drug targets in high-throughput screening (HTS) efforts, for the identification of lead compounds. However, different to the one-drug-one-target paradigm, chemogenomics attempts to identify all potential ligands for all possible targets and diseases. In this review, we summarize current methodological development efforts in drug repositioning that use state-of-the-art computational ligand- and structure-based chemogenomics approaches. Furthermore, we highlighted the recent progress in computational drug repositioning for some NTDs, based on curation and modeling of genomic, biological, and chemical data. Additionally, we also present in-house and other successful examples and suggest possible solutions to existing pitfalls.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据